Saturday, January 31, 2026 | 02:29 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Jenburkt Pharmaceuticals Ltd

Board Meeting Intimation for Considering And Approving Standalone Unaudited Financial Results For The Quarter And Nine Months Ended On 31St December 2025.

11:34 AM, 28th Jan 2026

Jenburkt Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 inter alia to consider and approve standalone unaudited financial results for the quarter and nine months ended On 31st December 2025.

More Jenburkt Pharmaceuticals Ltd Announcements